Clinical Trial Update: Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase II trial evaluating neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation for malignant pleural mesothelioma; the trial is completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Pleural Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2009-03-17